Very old NSCLC patients had a lower BMI and poor ECOG PS.
EGFR mutations reverse the poor prognosis of very old patients with NSCLC.
Young NSCLC patients had a lower BMI, more brain and bone metastases.
Young lung cancer patients have a poor prognosis even if they harbor EGFR mutations.